Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

Press releases published on May 5, 2026

May. 5, 2026

Health Canada Authorizes North America’s First Hepatitis B Rapid Test, bioLytical’s iStatis Hepatitis B Surface Antigen Test

Indeterminate GlobeNewswire

May. 5, 2026

Biosphere Awarded $9 Million U.S. Army Contract to Develop On-Demand Nutrition Production System for Warfighters

Indeterminate GlobeNewswire

May. 5, 2026

Cellution Biologics Celebrates Expansion of U.S. Headquarters in Roswell, Georgia

Indeterminate GlobeNewswire

May. 5, 2026

Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD

Indeterminate GlobeNewswire

May. 5, 2026

Clene Announces $7 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

May. 5, 2026

Ocugen Provides Business Update with First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May. 5, 2026

SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET

Indeterminate GlobeNewswire

May. 5, 2026

SS Innovations Surpasses 10,500 Surgeries Performed with the SSi Mantra Surgical Robotic System

Indeterminate GlobeNewswire

May. 5, 2026

Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

Indeterminate GlobeNewswire

May. 5, 2026

Sofwave Medical Reports First Quarter Fiscal 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

May. 5, 2026

Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

May. 5, 2026

Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

Indeterminate GlobeNewswire

May. 5, 2026

CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026

Indeterminate GlobeNewswire

May. 5, 2026

Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819

Indeterminate GlobeNewswire

May. 5, 2026

Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.

Indeterminate GlobeNewswire

May. 5, 2026

Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value

Indeterminate GlobeNewswire

May. 5, 2026

IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026

Indeterminate GlobeNewswire

May. 5, 2026

Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Indeterminate GlobeNewswire

May. 5, 2026

FibroBiologics CEO Issues Letter to Shareholders

Indeterminate GlobeNewswire

May. 5, 2026

Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes

Indeterminate GlobeNewswire